สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์
Printed on 06 December 2025 13:40

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To
 Reset

DOD BIOTECH PUBLIC COMPANY LIMITED : DOD

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 62 record(s) found)
NameYearStatusTypePeriodAs OfDetails
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ330/09/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedCompanyQ330/09/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ230/06/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedCompanyQ230/06/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ131/03/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedCompanyQ131/03/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2024AuditedConsolidatedYear31/12/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024AuditedCompanyYear31/12/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ330/09/2024
DOD BIOTECH PUBLIC COMPANY LIMITED2024ReviewedCompanyQ330/09/2024
Click here to display all results
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 12 record(s) found)
DateTimeHeadingLink
11/11/202518:24Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
13/08/202517:59Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
09/05/202506:35Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
19/02/202518:35Management Discussion and Analysis Yearly Ending 31 Dec 2024
07/11/202417:51Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
08/08/202421:28Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
09/05/202420:48Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
23/02/202408:41Management Discussion and Analysis Yearly Ending 31 Dec 2023
08/11/202319:33Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
11/08/202308:33Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
Click here to display all results
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found
Last updated on 05 December 2025